Charles Castano

Charles Castano serves as Chief Technology Officer at LabConnect. LabConnect operates in the pharmaceuticals sector with approximately 550.0 employees. The company is headquartered in Raleigh, North Carolina. LabConnect generates annual revenue of 36319000.0. To date, LabConnect has raised 28500000.0 in total funding, with the most recent round being Other.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • We have verified contacts for 2 executives at LabConnect.
• • 1,793 executive contacts are available in North Carolina.
• • Our database includes 201,469 c suite-level executives.

Salesforce Outlook Pardot Google Cloud Hosting WP Engine Jira Atlassian Confluence Barracuda Networks Bluekai Facebook Widget Facebook Custom Audiences Bootstrap Framework ASP.NET Linkedin Widget ON24 Mobile Friendly Facebook Login (Connect) Google Font API WordPress.org Google Tag Manager Shutterstock Linkedin Login Vimeo Nginx Google Analytics Remote Data Analytics Sigma

central laboratory services biological specimen collection storage distribution data management clinical kits biorepository logistics samplegistics fsp solutions lab kit production clinical trial sample management sample tracking project management cell gene therapy oncology biospecimen management clinical trial central lab support sample processing functional service provider data integration vaccine pharmaceutical manufacturing clinical trial support sample management clinical trial logistics vendor management scientific project management biomarker analysis cell & gene therapy vaccine development therapeutic expertise clinical research custom lab kits integrated data services clinical study oversight regulatory compliance flexible solutions end-to-end solutions clinical trial milestones global service network timely specimen collection accredited testing quality assurance patient-centric approach analytical solutions laboratory data integration logistics management clinical trial partners sample integrity clinical trial rescue real-time monitoring technical expertise clinical trial operations data consistency clinical data management investigator training strategic partnerships molecular testing flow cytometry fast turnaround research & development clinical trials patient data integration tailored solutions lab testing pharmaceutical global network operational efficiency agile solutions drug development scientific consulting pharmacogenomics advanced therapies immuno-oncology rare diseases customer-centric approach clinical pathology molecular diagnostics analytical chemistry global scalability customized support healthcare innovation patient care trial complexity international reach productivity hospital & health care enterprise software enterprises computer software information technology & services b2b pharmaceuticals medical health care health wellness & fitness

WW

Wes Wheeler CEO & Director at LabConnect

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

How can I contact Charles Castano?

Charles Castano's verified email address is available on MessageCEO. They currently work at LabConnect. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Charles Castano lead?

Charles Castano is Chief Technology Officer at LabConnect, a company in the pharmaceuticals sector with 550.0 employees. The company is based in Raleigh, North Carolina.

What industry is Charles Castano in?

Charles Castano works in the pharmaceuticals industry as Chief Technology Officer at LabConnect. MessageCEO provides verified contact information for executives across all major industries.

Is Charles Castano's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Charles Castano's profile is kept up-to-date with the latest available information.

Last updated: April 22, 2026